Thermo Fisher Scientific Inc. (TMO)
| Market Cap | 215.19B |
| Revenue (ttm) | 43.74B |
| Net Income (ttm) | 6.57B |
| Shares Out | 375.71M |
| EPS (ttm) | 17.32 |
| PE Ratio | 33.08 |
| Forward PE | 23.78 |
| Dividend | $1.72 (0.30%) |
| Ex-Dividend Date | Dec 15, 2025 |
| Volume | 1,873,581 |
| Open | 578.00 |
| Previous Close | 575.24 |
| Day's Range | 569.62 - 579.09 |
| 52-Week Range | 385.46 - 610.97 |
| Beta | 0.90 |
| Analysts | Buy |
| Price Target | 615.47 (+7.46%) |
| Earnings Date | Oct 22, 2025 |
About TMO
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for phar... [Read more]
Financial Performance
In 2024, Thermo Fisher's revenue was $42.88 billion, an increase of 0.05% compared to the previous year's $42.86 billion. Earnings were $6.34 billion, an increase of 5.67%.
Financial StatementsAnalyst Forecast
According to 18 analysts, the average rating for TMO stock is "Buy." The 12-month stock price target is $615.47, which is an increase of 7.46% from the latest price.
News
Thermo Fisher Scientific Deepens Investment in Asia's Biopharma Ecosystem with Expansion of Bioprocess Design Centers
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced an expansion of its bioprocessing capabilities across Asia, reinforcing its commitm...
Top 15 High-Growth Dividend Stocks For December 2025
The Top 15 High-Growth Dividend Stocks for December 2025 offer a 1.58% yield and 20.97% five-year dividend growth, appearing 33% undervalued. The watchlist's goal is a 12% long-term CAGR, with Novembe...
Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that it has priced an offering of €2.1 billion aggregate principal amount (the “Offering”) ...
Josh Brown's ‘best stocks in the market': Health Care
Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's 'Halftime Report' to explain why he's spotlighting Health Care in his "best stocks in the market." The Committee debates their health care s...
Thermo Fisher Scientific's Oncomine Dx Target Test Receives FDA Approval as a Companion Diagnostic to Identify Patients Eligible for Newest Targeted Therapy for Non-Small Cell Lung Cancer
CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, has received approval from the U.S. Food and Drug Administration (FDA) for its Ion Torrent™ Oncomine™ ...
Thermo Fisher Scientific Launches Industry-First, Multi-Parameter Molecular Assay for Rapid Beverage Quality Testing*
WALTHAM, Mass.--(BUSINESS WIRE)--To support the quality of beverage products, Thermo Fisher Scientific today introduced the Thermo Scientific™ SureTect™ Beverage Spoilage Multiplex qPCR Assay**, an in...
Thermo Fisher Scientific Opens East Coast Collaboration Center at BioLabs for Advanced Therapeutics to Help Accelerate Cell and Gene Therapy Development
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the grand opening of its East Coast flagship Advanced Therapies Collaboration Cente...
Final Trades: UnitedHealth, Thermo Fisher, Monster Beverage and the IYH
The Investment Committee give you their top stocks to watch for the second half.
Thermo Fisher Scientific Launches CorEvitas Clinical Registry in Myasthenia Gravis, a Rare Autoimmune Disorder
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the enrollment of the first patient in the new PPD™ CorEvitas™ Myasthenia Gravis (M...
Artisan Value Fund Q3 2025 Top Contributors And Detractors
Our biggest source of underperformance was the consumer staples sector as we had a number of laggards, including Kerry Group, Philip Morris and Diageo. On the positive side, the three new purchases we...
Final Trades: Kimberly-Clark, Thermo Fisher, Wabtec and Berkshire Hathaway
The Investment Committee give you their top stocks to watch for the second half.
The Big 3: TMO, DHR, VLO
As A.I. stocks take a beating on Wednesday's trading session, Dan Deming offers his thoughts and example options trades in healthcare and energy stocks. He explains his bullish theses behind Thermo Fi...
Thermo Fisher Scientific Receives 510(k) Clearance in the United States for EXENT System* to Aid in the Diagnosis of Multiple Myeloma
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced 510(k) clearance of the EXENT® Analyser and Immunoglobulin Isotypes (GA...
Thermo Fisher Scientific Authorizes $5 Billion of Share Repurchases
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized the repurchase of $5 billion...
Thermo Fisher Scientific Declares Quarterly Dividend
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0....
Thermo Fisher To Acquire Clario Holdings For $8.875 Billion, Expands Digital Pharma Capabilities
Thermo Fisher Scientific (NYSE:TMO) shares are trading higher on Wednesday after the company inked a deal to acquire Clario Holdings for $8.875 billion in cash, plus potential future earnout and other...
Thermo Fisher to buy clinical services provider Clario for up to $9.4 billion
Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion, strengthening its clinical trial research business amid a strong rebound in demand in...
Sethi: Thermo Fisher is a world-class compounder you want in your portfolio
Sarat Sethi, Managing Partner at DCLA, highlights opportunities in undervalued sectors like healthcare and diagnostics, says trade clarity could boost growth, and calls Thermo Fisher a standout pick.
Thermo Fisher Scientific Agrees to Buy Clario Holdings for $8.88 Billion
Thermo Fisher Scientific agreed to acquire endpoint data solutions provider Clario Holdings from a shareholder group for $8.88 billion in cash.
Thermo Fisher to buy clinical services provider Clario
Thermo Fisher said on Wednesday it would buy privately held data management company Clario for about $8.9 billion in cash and future payments, strengthening the life science firm's presence in digital...
Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a definitive agreement to acquire Clario Holdings, Inc., a leading prov...
14-year-old Combines Origami and Physics to Engineer Foldable Structures for Disaster Relief Shelters; Wins $25,000 Top Award at Thermo Fisher Scientific Junior Innovators Challenge
Miles Wu, 14, from New York City, won the $25,000 Thermo Fisher Scientific ASCEND Award, the top award in the Thermo Fisher Junior Innovators Challenge.
Thermo Fisher nears $10 billion takeover of drug trial software maker Clario, FT reports
Life sciences group Thermo Fisher is nearing an all-cash takeover of drug trial software maker Clario in a deal that could value the healthcare technology group at approximately $10 billion, the Finan...
Thermo Fisher Scientific Enables Semiconductor Manufacturers to See the Unseen with Helios MX1 PFIB-SEM
WALTHAM, Mass.--(BUSINESS WIRE)--From smartphones to autonomous cars to AI supercomputers, nearly every electronic innovation we use today depends on complicated structures at the atomic scale within ...
Thermo Fisher's Pullback Is Setting Up Its Next Phase of Growth
Bought 18,686 shares; estimated trade size ~$8.70 million based on quarterly average price for Q3 2025 Transaction represents 0.2% of fund's 13F reportable assets under management Post-trade position:...